Granite Investment Partners, LLC Rigel Pharmaceuticals Inc Transaction History
Granite Investment Partners, LLC
- $2.54 Billion
- Q1 2024
A detailed history of Granite Investment Partners, LLC transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Granite Investment Partners, LLC holds 10,578 shares of RIGL stock, worth $82,296. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,578Holding current value
$82,296% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding RIGL
# of Institutions
122Shares Held
110MCall Options Held
556KPut Options Held
33.9K-
Armistice Capital, LLC New York, NY15.4MShares$120 Million0.31% of portfolio
-
Black Rock Inc. New York, NY14.8MShares$115 Million0.0% of portfolio
-
Morgan Stanley New York, NY14.4MShares$112 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.37MShares$72.9 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT9.24MShares$71.9 Million1.12% of portfolio
About RIGEL PHARMACEUTICALS INC
- Ticker RIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 172,836,000
- Market Cap $1.34B
- Description
- Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...